| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.23 | 5e-12 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-06 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.22 | 3e-05 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-05 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.13 | 5e-05 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.2 | 0.0001 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.18 | 0.0006 |